Immunopathology of multiple sclerosis
Abstract
Two decades of clinical experience with immunomodulatory treatments for multiple sclerosis point to distinct immunological pathways that drive disease relapses and progression. In light of this, we discuss our current understanding of multiple sclerosis immunopathology, evaluate long-standing hypotheses regarding the role of the immune system in the disease and delineate key questions that are still unanswered. Recent and anticipated advances in the field of immunology, and the increasing recognition of inflammation as an important component of neurodegeneration, are shaping our conceptualization of disease pathophysiology, and we explore the potential implications for improved healthcare provision to patients in the future.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Extensive infiltration and activation of peripheral and resident immune cells in MS suggests these cells are key mediators of lesion formation.
“The extensive infiltration and activation of peripheral and resident immune cells in MS suggests these cells are key mediators of lesion formation [77, 210, 278] (Fig. 1j-l).”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [77]
In addition to possible antigen-specific T cell-mediated inflammation, non-specific inflammation also contributes to myelin destruction in MS.
“In addition to possible antigen-specific T cell-mediated inflammation, non-specific inflammation also contributes to myelin destruction in MS [77].”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [77]
Both ASD and MS have been characterised by immunological abnormalities and dysfunctional myelination, at least in a subset of individuals.
“Both conditions have been characterised by immunological abnormalities and dysfunctional myelination, at least in a subset of individuals [170,171].”
From Vitamin D and Autism Spectrum Disorder: A Literature Review (2016) · cites this paper as [171]
Microglial gene expression changes may contribute to risk for autoimmune disorders of the central nervous system such as multiple sclerosis and lupus.
“Furthermore, work from the past few years demonstrates that microglial gene expression changes during aging and may contribute to risk for AD (3) as well as autoimmune disorders of the central nervous system (CNS) such as multiple sclerosis [MS; reviewed in (4)] and lupus (5), but precisely how these cells contribute to risk for autoimmune disorders or AD remains unclear.”
From The Transcriptional Landscape of Microglial Genes in Aging and Neurodegenerative Disease (2019) · cites this paper as [4]
Cites
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815 · see citing works
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395 · see citing works
Integrative analysis of 111 reference human epigenomes
Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., et al. (2015) · Nature · doi:10.1038/nature14248 · Cited by 6,368 · see citing works
Compston, A., & Coles, A. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,459 · see citing works
Structural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413 · see citing works
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336 · see citing works
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062 · see citing works
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M., Ferguson, P., Whitesell, L., Kelly, T., Saulsbury, F., Chance, P., & Ochs, H. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,576 · see citing works
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439 · see citing works
Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors
Gomez Perdiguero, E., Klapproth, K., Schulz, C., Busch, K., Azzoni, E., Crozet, L., Garner, H., Trouillet, C., de Bruijn, M. F., Geissmann, F., et al. (2015) · Nature · doi:10.1038/nature13989 · Cited by 2,339 · see citing works
Genetic and epigenetic fine mapping of causal autoimmune disease variants
Farh, K. K.-H., Marson, A., Zhu, J., Kleinewietfeld, M., Housley, W. J., Beik, S., Shoresh, N., Whitton, H., Ryan, R. J. H., Shishkin, A. A., et al. (2015) · Nature · doi:10.1038/nature13835 · Cited by 1,956 · see citing works
International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895 · see citing works
Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin
Yednock, T. A., Cannon, C., Fritz, L. C., Sánchez‐Madrid, F., Steinman, L., & Karin, N. (1992) · Nature · doi:10.1038/356063a0 · Cited by 1,737 · see citing works
Uncovering disease-disease relationships through the incomplete interactome
Menche, J., Sharma, A., Kitsak, M., Ghiassian, S. D., Vidal, M., Loscalzo, J., & Barabási, A.-L. (2015) · Science · doi:10.1126/science.1257601 · Cited by 1,546 · see citing works
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450 · see citing works
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437 · see citing works
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Ghoreschi, K., Laurence, A., Yang, X.-P., Tato, C. M., McGeachy, M. J., Konkel, J. E., Ramos, H. L., Wei, L., Davidson, T. S., Bouladoux, N., et al. (2010) · Nature · doi:10.1038/nature09447 · Cited by 1,388 · see citing works
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International Multiple Sclerosis Genetics Consortium (IMSGC) (2013) · Nature Genetics · doi:10.1038/ng.2770 · Cited by 1,386 · see citing works
Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination
Berer, K., Mues, M., Koutrolos, M., Rasbi, Z. A., Boziki, M., Johner, C., Wekerle, H., & Krishnamoorthy, G. (2011) · Nature · doi:10.1038/nature10554 · Cited by 1,251 · see citing works
Homeostasis, Inflammation, and Disease Susceptibility
Kotas, M. E., & Medzhitov, R. (2015) · Cell · doi:10.1016/j.cell.2015.02.010 · Cited by 1,213 · see citing works
Codarri, L., Gyülvészi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T., & Becher, B. (2011) · Nature Immunology · doi:10.1038/ni.2027 · Cited by 1,191 · see citing works
Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J. A., Newcombe, J., Esiri, M. M., & Fugger, L. H. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070690 · Cited by 1,180 · see citing works
Self-citationVariation in the Human Immune System Is Largely Driven by Non-Heritable Influences
Brodin, P., Jojic, V., Gao, T., Bhattacharya, S., Angel, C. J. L., Furman, D., Shen-Orr, S., Dekker, C. L., Swan, G. E., Butte, A. J., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.020 · Cited by 1,065 · see citing works
Shen, P., Roch, T., Lampropoulou, V., O’Connor, R. A., Stervbo, U., Hilgenberg, E., Ries, S., Dang, V. D., Jaimes, Y., Daridon, C., et al. (2014) · Nature · doi:10.1038/nature12979 · Cited by 1,048 · see citing works
The anatomical and cellular basis of immune surveillance in the central nervous system
Ransohoff, R. M., & Engelhardt, B. (2012) · Nature reviews. Immunology · doi:10.1038/nri3265 · Cited by 975 · see citing works
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β
Zielinski, C. E., Mele, F., Aschenbrenner, D., Jarrossay, D., Ronchi, F., Gattorno, M., Monticelli, S., Lanzavecchia, A., & Sallusto, F. (2012) · Nature · doi:10.1038/nature10957 · Cited by 919 · see citing works
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
Howell, O. W., Reeves, C. A., Nicholas, R., Carassiti, D., Radotra, B., Gentleman, S. M., Serafini, B., Aloisi, F., Roncaroli, F., Magliozzi, R., et al. (2011) · Brain · doi:10.1093/brain/awr182 · Cited by 858 · see citing works
Differential roles of microglia and monocytes in the inflamed central nervous system
Yamasaki, R., Lu, H., Butovsky, O., Ohno, N., Rietsch, A. M., Cialic, R., Wu, P. M., Doykan, C. E., Lin, J., Cotleur, A. C., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132477 · Cited by 855 · see citing works
Lymphoid organ development: from ontogeny to neogenesis
Drayton, D. L., Liao, S., Mounzer, R. H., & Ruddle, N. H. (2006) · Nature Immunology · doi:10.1038/ni1330 · Cited by 777 · see citing works
Oxidative damage in multiple sclerosis lesions
Haider, L., Fischer, M. T., Frischer, J., Bauer, J., Höftberger, R., Botond, G., Esterbauer, H., Binder, C., Witztum, J., & Lassmann, H. (2011) · Brain : a journal of neurology · doi:10.1093/brain/awr128 · Cited by 754 · see citing works
Kappos, L., Li, D., Calabresi, P. A., O'Connor, P. W., Bar‐Or, A., Barkhof, F., Yin, M., Leppert, D., Glanzman, R., Tinbergen, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61649-8 · Cited by 743 · see citing works
Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis
McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H., & Miller, S. D. (2005) · Nature Medicine · doi:10.1038/nm1202 · Cited by 694 · see citing works
A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation
Goldmann, T., Wieghofer, P., Müller, P. F., Wolf, Y., Varol, D., Yona, S., Brendecke, S. M., Kierdorf, K., Staszewski, O., Datta, M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3531 · Cited by 688 · see citing works
Belbasis, L., Bellou, V., Εvangelou, Ε., Ioannidis, J. P. A., & Tzoulaki, I. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70267-4 · Cited by 669 · see citing works
for the Multiple Sclerosis Genetics Group, Gregory, S. G., Schmidt, S., Seth, P., Oksenberg, J. R., Hart, J., Prokop, A., Caillier, S. J., Ban, M., Goris, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2103 · Cited by 657 · see citing works
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
Barr, T., Shen, P., Brown, S., Lampropoulou, V., Roch, T., Lawrie, S., Fan, B.-L., O'Connor, R., Anderton, S., Bar-Or, A., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111675 · Cited by 650 · see citing works
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
Friese, M. A., Schattling, B., & Fugger, L. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.37 · Cited by 628 · see citing works
Self-citationAging-induced type I interferon response at the choroid plexus negatively affects brain function
Baruch, K., Deczkowska, A., David, E., Castellano, J. M., Miller, O., Kertser, A., Berkutzki, T., Barnett-Itzhaki, Z., Bezalel, D., Wyss-Coray, T., et al. (2014) · Science · doi:10.1126/science.1252945 · Cited by 615 · see citing works
The Virome in Mammalian Physiology and Disease
Virgin, H. W. (2014) · Cell · doi:10.1016/j.cell.2014.02.032 · Cited by 598 · see citing works
Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading
Miller, S. D., Vanderlugt, C. L., Begolka, W. S., Pao, W., Yauch, R. L., Neville, K. L., Katz-Levy, Y., Carrizosa, A., & Kim, B. S. (1997) · Nature Medicine · doi:10.1038/nm1097-1133 · Cited by 565 · see citing works
Preferential recruitment of interferon‐γ–expressing T <sub>H</sub> 17 cells in multiple sclerosis
Kebir, H., Ifergan, I., Alvarez, J. I., Bernard, M., Poirier, J., Arbour, N., Duquette, P., & Prat, A. (2009) · Annals of Neurology · doi:10.1002/ana.21748 · Cited by 551 · see citing works
Identification of T helper type 1–like, Foxp3+ regulatory T cells in human autoimmune disease
Dominguez-Villar, M., Baecher-Allan, C. M., & Hafler, D. A. (2011) · Nature Medicine · doi:10.1038/nm.2389 · Cited by 526 · see citing works
Fischer, M. T., Sharma, R., Lim, J. L., Haider, L., Frischer, J. M., Drexhage, J., Mahad, D., Bradl, M., van Horssen, J., & Lassmann, H. (2012) · Brain · doi:10.1093/brain/aws012 · Cited by 507 · see citing works
Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes
Raj, T., Rothamel, K., Mostafavi, S., Ye, C., Lee, M. N., Replogle, J. M., Feng, T., Lee, M., Asinovski, N., Frohlich, I., et al. (2014) · Science · doi:10.1126/science.1249547 · Cited by 506 · see citing works
Antiviral immune responses: triggers of or triggered by autoimmunity?
Münz, C., Lünemann, J. D., Getts, M. T., & Miller, S. D. (2009) · Nature reviews. Immunology · doi:10.1038/nri2527 · Cited by 480 · see citing works
Segal, B. M., Constantinescu, C. S., Raychaudhuri, A., Kim, L., Fidelus-Gort, R., & Kasper, L. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70173-x · Cited by 479 · see citing works
CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis
Fletcher, J. M., Lonergan, R. M., Costelloe, L., Kinsella, K., Moran, B., O’Farrelly, C., Tubridy, N. J., & Mills, K. H. G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901881 · Cited by 476 · see citing works
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation
Mayo, L., Trauger, S. A., Blain, M., Nadeau, M., Patel, B., Alvarez, J. I., Mascanfroni, I. D., Yeste, A., Kivisäkk, P., Kallas, K., et al. (2014) · Nature Medicine · doi:10.1038/nm.3681 · Cited by 472 · see citing works
Brain atrophy in clinically early relapsing–remitting multiple sclerosis
Chard, D., Griffin, C., Parker, G. J. M., Kapoor, R., Thompson, A. J., & Miller, D. H. (2002) · Brain · doi:10.1093/brain/awf025 · Cited by 459 · see citing works
Craner, M. J., Newcombe, J., Black, J. A., Hartle, C., Cuzner, M. L., & Waxman, S. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402765101 · Cited by 446 · see citing works
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
Stern, J. N. H., Yaari, G., Heiden, J. A. V., Church, G. M., Donahue, W. F., Hintzen, R. Q., Huttner, A. J., Laman, J. D., Nagra, R. M., Nylander, A. N., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008879 · Cited by 442 · see citing works
Scally, S. W., Petersen, J., Law, S. C., Dudek, N. L., Nel, H. J., Loh, K. L., Wijeyewickrema, L. C., Eckle, S. B. G., van Heemst, J., Pike, R. N., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20131241 · Cited by 429 · see citing works
Leypoldt, F., Armangué, T., & Dalmau, J. O. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12553 · Cited by 424 · see citing works
BACH2 represses effector programs to stabilize Treg-mediated immune homeostasis
Roychoudhuri, R., Hirahara, K., Mousavi, K., Clever, D. C., Klebanoff, C. A., Bonelli, M. M., Sciumè, G., Zare, H., Vahedi, G., Dema, B., et al. (2013) · Nature · doi:10.1038/nature12199 · Cited by 412 · see citing works
Friese, M. A., Craner, M. J., Etzensperger, R., Vergo, S. B., Wemmie, J. A., Welsh, M. J., Vincent, A. C., & Fugger, L. H. (2007) · Nature Medicine · doi:10.1038/nm1668 · Cited by 408 · see citing works
Self-citationShechter, R., London, A., & Schwartz, M. (2013) · Nature reviews. Immunology · doi:10.1038/nri3391 · Cited by 399 · see citing works
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
Choi, S. R., Howell, O. W., Carassiti, D., Magliozzi, R., Gveric, D., Muraro, P. A., Nicholas, R., Roncaroli, F., & Reynolds, R. (2012) · Brain · doi:10.1093/brain/aws189 · Cited by 386 · see citing works
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
Gregory, A., Dendrou, C. A., Attfield, K. E., Haghikia, A., Xifara, D. K., Butter, F., Poschmann, G., Kaur, G., Lambert, L., Leach, O. A., et al. (2012) · Nature · doi:10.1038/nature11307 · Cited by 384 · see citing works
Self-citationInhibition of Microglial Phagocytosis Is Sufficient To Prevent Inflammatory Neuronal Death
Neher, J. J., Neniskyte, U., Zhao, J.-W., Bal-Price, A., Tolkovsky, A. M., & Brown, G. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003600 · Cited by 373 · see citing works
Super-enhancers delineate disease-associated regulatory nodes in T cells
Vahedi, G., Kanno, Y., Furumoto, Y., Jiang, K., Parker, S. C. J., Erdos, M. R., Davis, S. R., Roychoudhuri, R., Restifo, N. P., Gadina, M., et al. (2015) · Nature · doi:10.1038/nature14154 · Cited by 369 · see citing works
Venken, K., Hellings, N., Thewissen, M. M., Somers, V. A., Hensen, K., Rummens, J., Medaer, R., Hupperts, R., & Stinissen, P. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02690.x · Cited by 358 · see citing works
Quan, N., Whiteside, M., & Herkenham, M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00350-3 · Cited by 335 · see citing works
Analysis of regulatory CD8 T cells in Qa-1-deficient mice
Hu, D., Ikizawa, K., Lu, L., Sanchirico, M. E., Shinohara, M. L., & Cantor, H. (2004) · Nature Immunology · doi:10.1038/ni1063 · Cited by 330 · see citing works
Microglial displacement of inhibitory synapses provides neuroprotection in the adult brain
Chen, Z., Jalabi, W., Hu, W., Park, H.-J., Gale, J. T., Kidd, G. J., Bernatowicz, R., Gossman, Z. C., Chen, J. T., Dutta, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms5486 · Cited by 319 · see citing works
Cytokine signals propagate through the brain
Vitković, L., Konsman, J. P., Bockaert, J., Dantzer, R., Homburger, V., & Jacque, C. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000813 · Cited by 306 · see citing works
Snyder, C. M., Cho, K. S., Bonnett, E. L., van Dommelen, S. L. H., SHELLAM, G. R., & Hill, A. B. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.017 · Cited by 300 · see citing works
Roederer, M., Quaye, L., Mangino, M., Beddall, M. H., Mahnke, Y., Chattopadhyay, P., Tosi, I., Napolitano, L., Terranova Barberio, M., Menni, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.02.046 · Cited by 296 · see citing works
Cao, Y., Goods, B. A., Raddassi, K., Nepom, G. T., Kwok, W. W., Love, J. C., & Hafler, D. A. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa8038 · Cited by 290 · see citing works
Lutterotti, A., Yousef, S., Sputtek, A., Stürner, K. H., Stellmann, J., Breiden, P., Reinhardt, S., Schulze, C., Bester, M., Heesen, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006168 · Cited by 282 · see citing works
Dendrou, C. A., Plagnol, V., Fung, E., Yang, J. H. M., Downes, K., Cooper, J. D., Nutland, S., Coleman, G., Himsworth, M., Hardy, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.434 · Cited by 274 · see citing works
Self-citationVenken, K., Hellings, N., Broekmans, T., Hensen, K., Rummens, J., & Stinissen, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.6411 · Cited by 261 · see citing works
Treatment of progressive multiple sclerosis: what works, what does not, and what is needed.
Feinstein, A., Freeman, J., & Lo, A. C. (2015) · Lancet Neurology · doi:10.1016/s1474-4422(14)70231-5 · Cited by 254 · see citing works
Bielekova, B., Sung, M., Kadom, N., Simon, R. M., McFarland, H. F., & Martinꝉ, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3893 · Cited by 241 · see citing works
Intersection of population variation and autoimmunity genetics in human T cell activation
Ye, C. J., Feng, T., Kwon, H.-K., Raj, T., Wilson, M. T., Asinovski, N., McCabe, C., Lee, M. H., Frohlich, I., Paik, H.-I., et al. (2014) · Science · doi:10.1126/science.1254665 · Cited by 236 · see citing works
IL-17 and GM-CSF Expression Are Antagonistically Regulated by Human T Helper Cells
Noster, R., Riedel, R., Mashreghi, M., Radbruch, H., Harms, L., Haftmann, C., Chang, H., Radbruch, A., & Zielinski, C. E. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008706 · Cited by 231 · see citing works
Pathology of demyelinating diseases.
Popescu, B. F. G., & Lucchinetti, C. (2012) · Annual Review of Pathology · doi:10.1146/annurev-pathol-011811-132443 · Cited by 228 · see citing works
A virus-induced molecular mimicry model of multiple sclerosis
Olson, J. K., Croxford, J. L., Calenoff, M. A., Canto, M. C. D., & Miller, S. D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13032 · Cited by 227 · see citing works
Palanichamy, A., Apeltsin, L., Kuo, T. C., Sirota, M., Wang, S., Pitts, S. J., Sundar, P. D., Telman, D., Zhao, L., Derstine, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008930 · Cited by 227 · see citing works
Miller, A., Shapiro, S., Gershtein, R., Kinarty, A., Rawashdeh, H., Honigman, S., & Lahat, N. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00191-x · Cited by 225 · see citing works
Therapeutic Induction of Regulatory, Cytotoxic CD8+ T Cells in Multiple Sclerosis
Tennakoon, D. K., Mehta, R. S., Ortega, S. B., Bhoj, V. G., Racke, M. K., & Karandikar, N. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.7119 · Cited by 207 · see citing works
Schattling, B., Steinbach, K., Thies, E., Kruse, M., Menigoz, A., Ufer, F., Flockerzi, V., Brück, W., Pongs, O., Vennekens, R., et al. (2012) · Nature Medicine · doi:10.1038/nm.3015 · Cited by 205 · see citing works
Self-citationFunctional epistasis on a common MHC haplotype associated with multiple sclerosis
Gregersen, J. W., Kranc, K. R., Ke, X., Svendsen, P., Madsen, L. S., Thomsen, A. R., Cardon, L. R., Bell, J. I., & Fugger, L. H. (2006) · Nature · doi:10.1038/nature05133 · Cited by 203 · see citing works
Self-citationAbsence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis
Sargsyan, S. A., Shearer, A. J., Ritchie, A. M., Burgoon, M. P., Anderson, S. W., Hemmer, B., Stadelmann, C., Gattenlöhner, S., Owens, G. P., Gilden, D., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d865a1 · Cited by 200 · see citing works
Feger, U., Luther, C., Poeschel, S., Melms, A., Tolosa, E., & Wiendl, H. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03271.x · Cited by 199 · see citing works
Yogev, N., Frommer, F., Lukas, D., Kautz-Neu, K., Karram, K., Ielo, D., von Stebut, E., Probst, H.-C., van den Broek, M., Riethmacher, D., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.025 · Cited by 197 · see citing works
Abrahamsson, S., Angelini, D. F., Dubinsky, A. N., Morel, E., Oh, U., Jones, J., Carassiti, D., Reynolds, R., Salvetti, M., Calabresi, P. A., et al. (2013) · Brain · doi:10.1093/brain/awt182 · Cited by 194 · see citing works
T Cell-Mediated Autoimmune Disease Due to Low-Affinity Crossreactivity to Common Microbial Peptides
Harkiolaki, M., Holmes, S. L., Svendsen, P., Gregersen, J. W., Jensen, L. T., McMahon, R. M., Friese, M. A., van Boxel, G., Etzensperger, R., Tzartos, J. S., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.01.009 · Cited by 188 · see citing works
Self-citationOpposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis
Friese, M. A., Jakobsen, K. B., Friis, L. S., Etzensperger, R., Craner, M. J., McMahon, R. M., Jensen, L. T., Huygelen, V., Jones, E. Y., Bell, J. I., et al. (2008) · Nature Medicine · doi:10.1038/nm.1881 · Cited by 184 · see citing works
Self-citationA virus-induced molecular mimicry model of multiple sclerosis
Olson, J. K., Croxford, J. L., Calenoff, M. A., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113032 · Cited by 176 · see citing works
Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells
Hartmann, F. J., Khademi, M., Aram, J., Ammann, S., Kockum, I. S., Constantinescu, C. S., Gran, B., Piehl, F., Olsson, T. P., Deak, L. C., et al. (2014) · Nature Communications · doi:10.1038/ncomms6056 · Cited by 171 · see citing works
Ji, Q., Perchellet, A., & Goverman, J. M. (2010) · Nature Immunology · doi:10.1038/ni.1888 · Cited by 167 · see citing works
Willing, A., Leach, O. A., Ufer, F., Attfield, K. E., Steinbach, K., Kursawe, N., Piédavent, M., & Friese, M. A. (2014) · European Journal of Immunology · doi:10.1002/eji.201344160 · Cited by 159 · see citing works
Self-citationBen‐Nun, A., Kaushansky, N., Kawakami, N., Krishnamoorthy, G., Berer, K., Liblau, R., Hohlfeld, R., & Wekerle, H. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.06.004 · Cited by 156 · see citing works
Shift work at young age is associated with increased risk for multiple sclerosis
Hedström, A. K., Åkerstedt, T., Hillert, J. A., Olsson, T. P., & Alfredsson, L. S. (2011) · Annals of Neurology · doi:10.1002/ana.22597 · Cited by 156 · see citing works
Schneider, A., Long, S. A., Cerosaletti, K. M., Ni, C., Samuels, P. L., Kita, M., & Buckner, J. H. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004970 · Cited by 154 · see citing works
Kolasinski, J., Stagg, C. J., Chance, S. A., DeLuca, G. C., Esiri, M. M., Chang, E.-H., Palace, J. A., McNab, J. A., Jenkinson, M., Miller, K. L., et al. (2012) · Brain · doi:10.1093/brain/aws242 · Cited by 153 · see citing works
Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity
Lundström, W., Highfill, S. L., Walsh, S. T. R., Beq, S., Morse, E., Kockum, I. S., Alfredsson, L. S., Olsson, T. P., Hillert, J. A., & Mackall, C. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222303110 · Cited by 150 · see citing works
IL‐10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis
Martínez‐Forero, I., García‐Muñoz, R., Martinez‐Pasamar, S., Inogés, S., de Cerio, A. L.-D., Palacios, R., Sepulcre, J., Moreno, B., Gonzalez, Z., Fernández-Díez, B., et al. (2008) · European Journal of Immunology · doi:10.1002/eji.200737271 · Cited by 141 · see citing works
T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls
Hellings, N., Bar�e, M., Verhoeven, C., D'hooghe, M. B., Medaer, R., Bernard, C. C. A., Raus, J., & Stinissen, P. (2001) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20010201)63:3 · Cited by 138 · see citing works
Lossius, A., Johansen, J. N., Vartdal, F., Robins, H. S., Benth, J. Š., Holmøy, T., & Olweus, J. (2014) · European Journal of Immunology · doi:10.1002/eji.201444662 · Cited by 130 · see citing works
Ji, Q., Castelli, L., & Goverman, J. M. (2013) · Nature Immunology · doi:10.1038/ni.2513 · Cited by 124 · see citing works
Relapsing–Remitting Central Nervous System Autoimmunity Mediated by GFAP-Specific CD8 T Cells
Sasaki, K., Bean, A., Shah, S., Schutten, E., Huseby, P. G., Peters, B., Shen, Z. T., Vanguri, V. K., Liggitt, D., & Huseby, E. S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302911 · Cited by 118 · see citing works
Cervical cord lesion load is associated with disability independently from atrophy in MS
KEARNEY, H. F., Altmann, D. R., Samson, R. S., Yiannakas, M. C., Wheeler‐Kingshott, C. A. M. G., Ciccarelli, O., & Miller, D. H. (2014) · Neurology · doi:10.1212/wnl.0000000000001186 · Cited by 113 · see citing works
Interferon beta induces T-helper 2 immune deviation in MS
Kozovska, M., Hong, J., Zang, Y. C. Q., Li, S., Rivera, V. M., Killian, J. M., & Zhang, J. Z. (1999) · Neurology · doi:10.1212/wnl.53.8.1692 · Cited by 111 · see citing works
A case‐control study of multiple sclerosis
Operskalski, E. A., Visscher, B. R., Malmgren, R. M., & Detels, R. (1989) · Neurology · doi:10.1212/wnl.39.6.825 · Cited by 107 · see citing works
Fritzsching, B., Haas, J., König, F. B., Kunz, P., Fritzsching, E., Pöschl, J. M. B., Krammer, P. H., Brück, W., Suri‐Payer, E., & Wildemann, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017988 · Cited by 106 · see citing works
Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome
Giannetti, P., Politis, M., Su, P., Turkheimer, F., Malik, O., Shiva Keihaninejad, A., Wu, K., Waldman, A. D., Reynolds, R., Nicholas, R. S., et al. (2014) · Brain · doi:10.1093/brain/awu331 · Cited by 106 · see citing works
Therapies for multiple sclerosis: translational achievements and outstanding needs
Haghikia, A., Hohlfeld, R., Gold, R., & Fugger, L. H. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.03.004 · Cited by 105 · see citing works
Self-citationSelecting causal genes from genome-wide association studies via functionally coherent subnetworks
Taşan, M., Musso, G. A., Hao, T., Vidal, M., MacRae, C. A., & Roth, F. P. (2014) · Nature Methods · doi:10.1038/nmeth.3215 · Cited by 97 · see citing works
Brickshawana, A., Hinson, S. R., Romero, M. F., Lucchinetti, C. F., Guo, Y. X., Buttmann, M., McKeon, A. B., Pittock, S. J., Chang, M.-H., Chen, A., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70141-3 · Cited by 83 · see citing works
Baughman, E. J., Mendoza, J. P., Ortega, S. B., Ayers, C. L., Greenberg, B. M., Frohman, E. M., & Karandikar, N. J. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.12.003 · Cited by 75 · see citing works
IFN-β Treatment Requires B Cells for Efficacy in Neuroautoimmunity
Schubert, R. D., Hu, Y., Kumar, G., Szeto, S., Abraham, P., Winderl, J., Guthridge, J. M., Pardo, G., Dunn, J., Steinman, L., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402029 · Cited by 73 · see citing works
Neuromyelitis Optica and Asian Phenotype of Multiple Sclerosis
Kira, J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1444.002 · Cited by 64 · see citing works
Frisullo, G., Nociti, V., Iorio, R., Patanella, A. K., Marti, A., Caggiula, M., Massimiliano Mirabella, A., Tonali, P. A., & Batocchi, A. P. (2008) · Cytokine · doi:10.1016/j.cyto.2008.08.007 · Cited by 61 · see citing works
Thymic involution and proliferative T-cell responses in multiple sclerosis
Duszczyszyn, D. A., Williams, J. L., Mason, H., Lapierre, Y., Antel, J. P., & Haegert, D. G. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.02.005 · Cited by 60 · see citing works
Siewert, K., Malotka, J., Kawakami, N., Wekerle, H., Hohlfeld, R., & Dornmair, K. (2012) · Nature Medicine · doi:10.1038/nm.2720 · Cited by 60 · see citing works
Weisfeld‐Adams, J. D., Sand, I. K., Honce, J. M., & LUBLIN, F. D. (2015) · Brain · doi:10.1093/brain/awu397 · Cited by 59 · see citing works
Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis
Campbell, G. R., Kraytsberg, Y., Krishnan, K. J., Ohno, N., Ziabreva, I., Reeve, A. K., Trapp, B. D., Newcombe, J., Reynolds, R., Lassmann, H., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1001-9 · Cited by 53 · see citing works
Bhela, S., Kempsell, C., Manohar, M., Dominguez‐Villar, M., Griffin, R. L., Bhatt, P. M., Kivisakk-Webb, P., Fuhlbrigge, R. C., Kupper, T. S., Weiner, H. L., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1303257 · Cited by 48 · see citing works
Mattoscio, M., Nicholas, R. S., Sormani, M. P., Malik, O., Lee, J. S., Waldman, A. D., Dazzi, F., & Muraro, P. A. (2015) · Neurology · doi:10.1212/wnl.0000000000001454 · Cited by 30 · see citing works
Zoghi, S., Amirghofran, Z., Nikseresht, A., Ashjazadeh, N., Kamali‐Sarvestani, E., & Rezaei, N. (2011) · Immunological Investigations · doi:10.3109/08820139.2011.569626 · Cited by 27 · see citing works
HLA-E restricted CD8 + T cell subsets are phenotypically altered in multiple sclerosis patients
Pannemans, K., Broux, B., Goris, A., Dubois, B., Broekmans, T., Wijmeersch, B. V., Geraghty, D. E., Stinissen, P., & Hellings, N. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513509703 · Cited by 21 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286 · see citing works
Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562 · see citing works
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Olsson, T. P., Barcellos, L. F., & Alfredsson, L. S. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.187 · Cited by 1,184 · see citing works
CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature.
Louveau, A., Herz, J., Alme, M. N., Salvador, A. F., Dong, M. Q., Viar, K. E., Herod, S. G., Knopp, J., Setliff, J. C., Lupi, A. L., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0227-9 · Cited by 956 · see citing works
Multiple Sclerosis: Mechanisms and Immunotherapy
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938 · see citing works
An updated histological classification system for multiple sclerosis lesions
Kuhlmann, T., Ludwin, S., Prat, A., Antel, J., Brück, W., & Lassmann, H. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1653-y · Cited by 692 · see citing works
The role of peripheral immune cells in the CNS in steady state and disease
Prinz, M., & Priller, J. (2017) · Nature Neuroscience · doi:10.1038/nn.4475 · Cited by 657 · see citing works
Luczynski, P., McVey Neufeld, K.-A., Oriach, C. S., Clarke, G., Dinan, T. G., & Cryan, J. F. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw020 · Cited by 632 · see citing works
Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota
Cignarella, F., Cantoni, C., Ghezzi, L., Salter, A., Dorsett, Y., Chen, L., Phillips, D., Weinstock, G. M., Fontana, L., Cross, A. H., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.006 · Cited by 568 · see citing works
Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders
Riazifar, M., Mohammadi, M. R., Pone, E. J., Yeri, A., Lässer, C., Segaliny, A. I., McIntyre, L. L., Shelke, G. V., Hutchins, E., Hamamoto, A., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b01004 · Cited by 551 · see citing works
Elucidation of Exosome Migration Across the Blood–Brain Barrier Model In Vitro
Chen, C. C., Liu, L., Ma, F., Wong, C. W., Guo, X. E., Chacko, J. V., Farhoodi, H. P., Zhang, S. X., Zimak, J., Ségaliny, A., et al. (2016) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-016-0458-3 · Cited by 537 · see citing works
Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo
Absinta, M., Sati, P., Masuzzo, F., Nair, G., Sethi, V., Kolb, H., Ohayon, J., Wu, T., Cortese, I. C. M., & Reich, D. S. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.2399 · Cited by 534 · see citing works
McKenzie, B., Mamik, M. K., Saito, L. B., Boghozian, R., Monaco, M. C., Major, E. O., Lu, J., Branton, W. G., & Power, C. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722041115 · Cited by 515 · see citing works
Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis
Jelčić, I., Nimer, F. A., Wang, J., Lentsch, V., Planas, R., Jelčić, I., Madjovski, A., Ruhrmann, S., Faigle, W., Frauenknecht, K. B. M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.011 · Cited by 510 · see citing works
Microglia in Central Nervous System Inflammation and Multiple Sclerosis Pathology
Voet, S., Prinz, M., & van Loo, G. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.11.005 · Cited by 503 · see citing works
The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond
Dostert, C., Grusdat, M., Letellier, E., & Brenner, D. (2018) · Physiological Reviews · doi:10.1152/physrev.00045.2017 · Cited by 502 · see citing works
Nonclassical Monocytes in Health and Disease
Narasimhan, P. B., Marcovecchio, P., Hamers, A. A. J., & Hedrick, C. C. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053119 · Cited by 475 · see citing works
Exercise in patients with multiple sclerosis
Motl, R. W., Sandroff, B. M., Kwakkel, G., Dalgas, U., Feinstein, A., Heesen, C., Feys, P., & Thompson, A. J. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30281-8 · Cited by 459 · see citing works
The Gut Microbiota in Immune-Mediated Inflammatory Diseases
Forbes, J. D., Domselaar, G. V., & Bernstein, C. N. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01081 · Cited by 430 · see citing works
Astrocytes in human central nervous system diseases: a frontier for new therapies
Verkhratsky, A., Butt, A., Li, B., Illes, P., Zorec, R., Semyanov, A., Tang, Y., & Sofroniew, M. V. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01628-9 · Cited by 428 · see citing works
Balancing the immune response in the brain: IL-10 and its regulation
Lobo‐Silva, D., Carriche, G. M., Castro, A. G., Roque, S., & Saraiva, M. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0763-8 · Cited by 427 · see citing works
Estrogens, Neuroinflammation, and Neurodegeneration
Villa, A., Vegeto, E., Poletti, A., & Maggi, A. (2016) · Endocrine Reviews · doi:10.1210/er.2016-1007 · Cited by 423 · see citing works
The spectrum of T cell metabolism in health and disease
Bantug, G. R., Galluzzi, L., Kroemer, G., & Hess, C. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.99 · Cited by 421 · see citing works
The progress of gut microbiome research related to brain disorders
Zhu, S., Jiang, Y., Xu, K., Cui, M., Ye, W., Zhao, G., Jin, L., & Chen, X. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1705-z · Cited by 419 · see citing works
Fecal Microbiota Transplantation in Neurological Disorders
Vendrik, K. E. W., Ooijevaar, R. E., de Jong, P. R. C., Laman, J. D., van Oosten, B. W., van Hilten, J. J., Ducarmon, Q. R., Keller, J. J., Kuijper, E. J., & Contarino, M. F. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00098 · Cited by 413 · see citing works
Reassessing B cell contributions in multiple sclerosis
Li, R., Patterson, K. R., & Bar‐Or, A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0135-x · Cited by 397 · see citing works
γδ T cells: origin and fate, subsets, diseases and immunotherapy
Hu, Y., Hu, Q., Li, Y., Lu, L., Xiang, Z., Yin, Z., Kabelitz, D., & Wu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01653-8 · Cited by 395 · see citing works
Erickson, M. A., & Banks, W. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014647 · Cited by 394 · see citing works
Resurrection of endogenous retroviruses during aging reinforces senescence
Liu, X., Liu, Z., Wu, Z., Ren, J., Fan, Y., Sun, L., Cao, G., Niu, Y., Zhang, B., Ji, Q., et al. (2023) · Cell · doi:10.1016/j.cell.2022.12.017 · Cited by 390 · see citing works
Kanmani, S., & Koo, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207551 · Cited by 381 · see citing works
Microglia in Retinal Degeneration
Rashid, K., Akhtar‐Schäfer, I., & Langmann, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01975 · Cited by 354 · see citing works
Ferroptosis in health and disease
Berndt, C., Alborzinia, H., Skafar, V., Ayton, S., Barayeu, U., Bartelt, A., Bayır, H., Bebber, C. M., Birsoy, K., Böttcher, J. P., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103211 · Cited by 354 · see citing works
Self-citationRemyelination in multiple sclerosis: From basic science to clinical translation
Lubetzki, C., Zalc, B., Williams, A., Stadelmann, C., & Stankoff, B. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30140-x · Cited by 350 · see citing works
Alves de Lima, K., Rustenhoven, J., & Kipnis, J. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-102319-103410 · Cited by 348 · see citing works
Methionine Metabolism Shapes T Helper Cell Responses through Regulation of Epigenetic Reprogramming
Roy, D. G., Chen, J., Mamane, V. H., Ma, E. H., Muhire, B. M., Sheldon, R. D., Shorstova, T., Koning, R., Johnson, R. M., Esaulova, E., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.01.006 · Cited by 347 · see citing works
The Immune Response in Multiple Sclerosis
Murúa, S. R., Farez, M., & Quintana, F. J. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-052920-040318 · Cited by 347 · see citing works
Oligodendroglia: metabolic supporters of neurons
Philips, T., & Rothstein, J. D. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90610 · Cited by 346 · see citing works
The anatomy and immunology of vasculature in the central nervous system
Mastorakos, P., & McGavern, D. (2019) · Science Immunology · doi:10.1126/sciimmunol.aav0492 · Cited by 333 · see citing works
Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson's disease
Sommer, A., Marxreiter, F., Krach, F., Fadler, T., Grosch, J., Maroni, M., Graef, D., Eberhardt, E., Riemenschneider, M. J., Yeo, G. W., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.06.015 · Cited by 332 · see citing works
B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers
van Langelaar, J., Rijvers, L., Smolders, J., & van Luijn, M. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00760 · Cited by 328 · see citing works
Intestinal dysbiosis and probiotic applications in autoimmune diseases
de Oliveira, G. L. V., Leite, A. Z., Higuchi, B. S., Gonzaga, M. I., & Mariano, V. S. (2017) · Immunology · doi:10.1111/imm.12765 · Cited by 321 · see citing works
Yan, Z., Gibson, S. A., Buckley, J. A., Qin, H., & Benveniste, E. N. (2018) · Clinical Immunology · doi:10.1016/j.clim.2016.09.014 · Cited by 318 · see citing works
The IL-1β phenomena in neuroinflammatory diseases
Mendiola, A. S., & Cardona, A. E. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1732-9 · Cited by 311 · see citing works
Gut Microbiota Regulation of T Cells During Inflammation and Autoimmunity
Brown, E., Kenny, D. J., & Xavier, R. J. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041841 · Cited by 310 · see citing works
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis
Muraro, P. A., Martinꝉ, R., Mancardi, G., Nicholas, R. S., Sormani, M. P., & Saccardi, R. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.81 · Cited by 308 · see citing works
Chu, F., Shi, M., Zheng, C., Shen, D., Zhu, J., Zheng, X., & Cui, L. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.02.015 · Cited by 304 · see citing works
Song, Y., Li, J., & Wu, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01952-8 · Cited by 301 · see citing works
Endoplasmic reticulum stress and inflammation in the central nervous system
Sprenkle, N. T., Sims, S. G., Sánchez, C. L., & Meares, G. P. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0183-y · Cited by 299 · see citing works
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity
Zhang, Q., & Vignali, D. A. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.017 · Cited by 298 · see citing works
Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights
Coutinho, D. D. S., Pacheco, M. T., Frozza, R. L., & Bernardi, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061812 · Cited by 298 · see citing works
Immune Responses Regulated by Cannabidiol
Nichols, J. M., & Kaplan, B. L. F. (2019) · Cannabis and Cannabinoid Research · doi:10.1089/can.2018.0073 · Cited by 297 · see citing works
Mitochondrial Dysfunction and Multiple Sclerosis
de Barcelos, I. P., Troxell, R. M., & Graves, J. (2019) · Biology · doi:10.3390/biology8020037 · Cited by 293 · see citing works
Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology?
Grussu, F., Schneider, T., Tur, C., Yates, R. L., Tachrount, M., Ianuş, A., Yiannakas, M. C., Newcombe, J., Zhang, H., Alexander, D. C., et al. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.445 · Cited by 291 · see citing works
The Role of Natural Killer Cells in Autoimmune Diseases
Küçüksezer, U. C., Çetin, E. A., Esen, F., Tahralı, İ., Akdeniz, N., Gelmez, M. Y., & Deniz, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.622306 · Cited by 290 · see citing works
Human Endogenous Retroviruses in Neurological Diseases
Küry, P., Nath, A., Créange, A., Dolei, A., Marche, P. N., Gold, J., Giovannoni, G., Hartung, H., & Perron, H. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.02.007 · Cited by 289 · see citing works
Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases
Shen, Z., Huang, W., Liu, J., Tian, J., Wang, S., & Rui, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.749192 · Cited by 281 · see citing works
Qin, H., Buckley, J. A., Li, X., Liu, Y., Fox, T. H., Meares, G. P., Yu, H., Yan, Z., Harms, A. S., Li, Y., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4658-15.2016 · Cited by 275 · see citing works
Environmental control of astrocyte pathogenic activities in CNS inflammation
Wheeler, M. A., Jaronen, M., Covacu, R., Zandee, S. E. J., Scalisi, G., Rothhammer, V., Tjon, E. C., Chao, C., Kenison, J. E., Blain, M., et al. (2019) · Cell · doi:10.1016/j.cell.2018.12.012 · Cited by 225 · see citing works
Neurological Disease as a Failure of Brain-Immune Crosstalk: The Multiple Faces of Neuroinflammation
Schwartz, M., & Deczkowska, A. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.08.001 · Cited by 246 · see citing works
Neurosteroids as regulators of neuroinflammation
Yılmaz, C., Karali, K., Fodelianaki, G., Gravanis, A., Chavakis, T., Charalampopoulos, I., & Alexaki, V. I. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100788 · Cited by 245 · see citing works
Lifestyle and Environmental Factors in Multiple SclerosisPreprint
Alfredsson, L. S., & Olsson, T. P. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028944 · Cited by 244 · see citing works
Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders
Caldito, N. G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1213448 · Cited by 240 · see citing works
The critical role of Faecalibacterium prausnitzii in human health: An overview
Leylabadlo, H. E., Ghotaslou, R., Feizabadi, M. M., Farajnia, S., Moaddab, S. Y., Ganbarov, K., Khodadadi, E., Tanomand, A., Sheykhsaran, E., Yousefi, B., et al. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104344 · Cited by 239 · see citing works
The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years
Baranzini, S. E., & Oksenberg, J. R. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.09.004 · Cited by 238 · see citing works
Slota, J. A., & Booth, S. A. (2019) · Non-Coding RNA · doi:10.3390/ncrna5020035 · Cited by 233 · see citing works
T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis
Kunkl, M., Frascolla, S., Amormino, C., Volpe, E., & Tuosto, L. (2020) · Cells · doi:10.3390/cells9020482 · Cited by 232 · see citing works
Can We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?
Kim, M. J., Kang, J. H., Theotokis, P., Grigoriadis, N., & Petratos, S. (2018) · Cells · doi:10.3390/cells8010001 · Cited by 228 · see citing works
Fransen, N. L., Hsiao, C., van der Poel, M., Engelenburg, H. J., Verdaasdonk, K., Vincenten, M. C. J., Remmerswaal, E. B. M., Kuhlmann, T., Mason, M. R. J., Hamann, J., et al. (2020) · Brain · doi:10.1093/brain/awaa117 · Cited by 227 · see citing works
van Langelaar, J., de Vries, R. M. V. D. V., Janssen, M., Wierenga‐Wolf, A. F., Spilt, I. M., Siepman, T. A. M., Dankers, W., Verjans, G. M. G. M., de Vries, H. E., Lubberts, E., et al. (2018) · Brain · doi:10.1093/brain/awy069 · Cited by 224 · see citing works
Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis
Kimura, K., Hohjoh, H., Fukuoka, M., Sato, W., Oki, S., Tomi, C., Yamaguchi, H., Kondo, T., Takahashi, R., & Yamamura, T. (2017) · Nature Communications · doi:10.1038/s41467-017-02406-2 · Cited by 222 · see citing works
Wang, Y., Hu, J., Wu, S., Fleishman, J. S., Li, Y., Xu, Y.-S., Zou, W., Wang, J., Feng, Y., Chen, J., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01720-0 · Cited by 220 · see citing works
MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function
Sugiura, A., Andrejeva, G., Voss, K., Heintzman, D. R., Xu, X., Madden, M. Z., Ye, X., Beier, K. L., Chowdhury, N. U., Wolf, M. M., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.10.011 · Cited by 219 · see citing works
Spaas, J., van Veggel, L., Schepers, M., Tiane, A., van Horssen, J., Wilson, D. M., Moya, P. R., Piccart, E., Hellings, N., Eijnde, B. O., et al. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03802-0 · Cited by 217 · see citing works
Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function
Spiteri, A. G., Wishart, C. L., Pamphlett, R., Locatelli, G., & King, N. J. C. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02384-2 · Cited by 216 · see citing works
“APCs play an important role in the activation of peripherally-primed T cells, resulting in an inflammatory cascade that leads to oligodendrocyte death, chronic demyelination, and neuronal loss [64, 77].”
BackgroundPredicting cognitive decline in multiple sclerosis: a 5-year follow-up study
Eijlers, A. J. C., van Geest, Q., Dekker, I., Steenwijk, M. D., Meijer, K. A., Hulst, H. E., Barkhof, F., Uitdehaag, B. M. J., Schoonheim, M. M., & Geurts, J. J. G. (2018) · Brain · doi:10.1093/brain/awy202 · Cited by 214 · see citing works
Rituximab for the treatment of multiple sclerosis: a review
Chisari, C. G., Sgarlata, E., Arena, S., Toscano, S., Luca, M., & Patti, F. (2021) · Journal of Neurology · doi:10.1007/s00415-020-10362-z · Cited by 209 · see citing works
Bruton tyrosine kinase inhibitors for multiple sclerosis
Krämer, J., Bar-Or, A., Turner, T. J., & Wiendl, H. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00800-7 · Cited by 206 · see citing works
Gut Microbiota, Leaky Gut, and Autoimmune Diseases
Christovich, A., & Luo, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.946248 · Cited by 206 · see citing works
Chidambaram, S. B., Essa, M. M., Rathipriya, A. G., Bishir, M., Ray, B., Mahalakshmi, A. M., Tousif, A. H., Sakharkar, M. K., Kashyap, R. S., Friedland, R. P., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107988 · Cited by 204 · see citing works
CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis
Fischbach, F., Richter, J., Pfeffer, L. K., Fehse, B., Berger, S. C., Reinhardt, S., Kühle, J., Badbaran, A., Rathje, K., Gagelmann, N., et al. (2024) · Med · doi:10.1016/j.medj.2024.03.002 · Cited by 201 · see citing works
Self-citationChen, T., Dai, Y., Hu, C., Lin, Z., Wang, S., Yang, J., Zeng, L., Li, S., & Li, W. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00557-1 · Cited by 201 · see citing works
How and why do T cells and their derived cytokines affect the injured and healthy brain?
Filiano, A. J., Gadani, S. P., & Kipnis, J. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.39 · Cited by 199 · see citing works
Kaunzner, U. W., Kang, Y., Zhang, S., Morris, E., Yao, Y., Pandya, S., Hurtado Rua, S. M., Park, C., Gillen, K. M., Nguyen, T. D., et al. (2019) · Brain · doi:10.1093/brain/awy296 · Cited by 199 · see citing works
Sevenich, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00697 · Cited by 199 · see citing works
Functions and regulation of T cell-derived interleukin-10
Neumann, C., Scheffold, A., & Rutz, S. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101344 · Cited by 199 · see citing works
Zhang, J., Buller, B., Zhang, Z. G., Zhang, Y., Lü, M., Rosene, D. L., Medalla, M., Moore, T. L., & Chopp, M. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113895 · Cited by 195 · see citing works
Inflammation-related plasma and CSF biomarkers for multiple sclerosis
Huang, J., Khademi, M., Fugger, L., Lindhe, Ö., Novakova, L., Axelsson, M., Malmeström, C., Constantinescu, C., Lycke, J., Piehl, F., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912839117 · Cited by 194 · see citing works
Self-citationThe neuropathobiology of multiple sclerosis
Woo, M. S., Engler, J. B., & Friese, M. A. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00823-z · Cited by 194 · see citing works
Self-citationP2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis
Zabala, A., Vazquez‐Villoldo, N., Rissiek, B., Gejo, J., Martin, A., Palomino, A., Perez‐Samartín, A., Pulagam, K. R., Lukowiak, M., Capetillo‐Zarate, E., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708743 · Cited by 192 · see citing works
Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins
Brändle, S. M., Obermeier, B., Şenel, M., Bruder, J., Mentele, R., Khademi, M., Olsson, T. P., Tumani, H., Kristoferitsch, W., Lottspeich, F., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522730113 · Cited by 191 · see citing works
Virtual reality in multiple sclerosis rehabilitation: A review on cognitive and motor outcomes
Maggio, M. G., Russo, M., Cuzzola, M. F., Destro, M., Rosa, G. L., Molonia, F., Bramanti, P., Lombardo, G., Luca, R. D., & Calabrò, R. S. (2019) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2019.03.017 · Cited by 191 · see citing works
Duarte, L. F., Farías, M. A., Álvarez, D. M., Bueno, S. M., Riedel, C. A., & González, P. A. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00046 · Cited by 189 · see citing works
The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials
Schepici, G., Silvestro, S., Bramanti, P., & Mazzon, E. (2019) · Cell Transplantation · doi:10.1177/0963689719873890 · Cited by 187 · see citing works
TREM2-dependent lipid droplet biogenesis in phagocytes is required for remyelination
Gouna, G., Klose, C., Bosch-Queralt, M., Liu, L., Gokce, O., Schifferer, M., Cantuti-Castelvetri, L., & Simons, M. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20210227 · Cited by 186 · see citing works
Epidemiology and Pathophysiology of Multiple Sclerosis
Ward, M., & Goldman, M. D. (2022) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001136 · Cited by 185 · see citing works
CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities
Franklin, R. J. M., & Simons, M. (2022) · Neuron · doi:10.1016/j.neuron.2022.09.023 · Cited by 184 · see citing works
GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosis
Galli, E., Hartmann, F. J., Schreiner, B., Ingelfinger, F., Arvaniti, E., Diebold, M., Mrdjen, D., van der Meer, F., Krieg, C., Nimer, F. A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0521-4 · Cited by 184 · see citing works
The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases
DeMaio, A., Mehrotra, S., Sambamurti, K., & Husain, S. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02605-9 · Cited by 184 · see citing works
Fas–Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis
Volpe, E., Sambucci, M., Battistini, L., & Borsellino, G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00382 · Cited by 182 · see citing works
He, B., Hoang, T. K., Tian, X., Taylor, C. M., Blanchard, E., Luo, M., Bhattacharjee, M. B., Freeborn, J., Park, S., Couturier, J. P., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00385 · Cited by 182 · see citing works
- Authors
- Dendrou, C. A., Fugger, L., & Friese, M. A.
- Affiliations
- John Radcliffe Hospital (GB)
- Aarhus University Hospital (DK)
- University Medical Center Hamburg-Eppendorf (DE)
- Corresponding author
- Fugger, Lars
- Venue
- Nature Reviews Immunology
- Published
- 2015-08-07
- Volume
- 15
- Issue
- 9
- Pages
- 545-558
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1828576284
- Cited by
- 2,215
- References
- 122
- Citations by year
- 2026: 117 · 2025: 177 · 2024: 243 · 2023: 230 · 2022: 252 · 2021: 272 · 2020: 257 · 2019: 216 · 2018: 201 · 2017: 159 · 2016: 83 · 2015: 5 · 2014: 1
- FWCI
- 21.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (100308/Z/12/Z, 100308)
- Alan and Babette Sainsbury Charitable Fund
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- multiple sclerosis, immunopathology, genetic susceptibility, environmental triggers, neuroinflammation, neurodegeneration, immunomodulatory therapy, recurrence, disease progression
- MeSH terms
- Environmental Exposure, Humans, Inflammation, Multiple Sclerosis, Autoimmunity, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review